These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21278615)

  • 1. Impact of 123I-FP-CIT (DaTSCAN) SPECT on the diagnosis and management of patients with dementia with Lewy bodies: a retrospective study.
    Kemp PM; Clyde K; Holmes C
    Nucl Med Commun; 2011 Apr; 32(4):298-302. PubMed ID: 21278615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
    Walker Z; Jaros E; Walker RW; Lee L; Costa DC; Livingston G; Ince PG; Perry R; McKeith I; Katona CL
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1176-81. PubMed ID: 17353255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.
    Brigo F; Turri G; Tinazzi M
    J Neurol Sci; 2015 Dec; 359(1-2):161-71. PubMed ID: 26671107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies.
    van der Zande JJ; Booij J; Scheltens P; Raijmakers PG; Lemstra AW
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1060-6. PubMed ID: 26830298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
    Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies.
    Kemp PM; Hoffmann SA; Tossici-Bolt L; Fleming JS; Holmes C
    Nucl Med Commun; 2007 Jun; 28(6):451-6. PubMed ID: 17460535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of
    Maltais DD; Jordan LG; Min HK; Miyagawa T; Przybelski SA; Lesnick TG; Reichard RR; Dickson DW; Murray ME; Kantarci K; Boeve BF; Lowe VJ
    J Nucl Med; 2020 Nov; 61(11):1628-1635. PubMed ID: 32198310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review.
    Jreige M; Kurian GK; Perriraz J; Potheegadoo J; Bernasconi F; Stampacchia S; Blanke O; Alessandra G; Lejay N; Chiabotti PS; Rouaud O; Nicod Lalonde M; Schaefer N; Treglia G; Allali G; Prior JO
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1988-2035. PubMed ID: 36920494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The applicability of 123I-FP-CIT SPECT dopamine transporter imaging in clinical practice].
    Perlaki G; Szekeres S; Janszky J; Dezső D; Aschermann Z; Zámbó K; Kovács N
    Ideggyogy Sz; 2019 Nov; 72(11-12):381-388. PubMed ID: 31834681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of ¹²³I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies.
    Papathanasiou ND; Boutsiadis A; Dickson J; Bomanji JB
    Parkinsonism Relat Disord; 2012 Mar; 18(3):225-9. PubMed ID: 21975260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
    Thomas AJ; Attems J; Colloby SJ; O'Brien JT; McKeith I; Walker R; Lee L; Burn D; Lett DJ; Walker Z
    Neurology; 2017 Jan; 88(3):276-283. PubMed ID: 27940650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.
    Walker Z; Cummings JL
    Alzheimers Dement; 2012 Jan; 8(1):74-83. PubMed ID: 22024052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
    Tang Z; Hirano S; Koizumi Y; Izumi M; Kitayama Y; Yamagishi K; Tamura M; Ishikawa A; Kashiwado K; Iimori T; Mukai H; Yokota H; Horikoshi T; Uno T; Kuwabara S
    J Alzheimers Dis; 2024; 100(1):127-137. PubMed ID: 38848178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.
    Walker Z; Costa DC; Walker RW; Shaw K; Gacinovic S; Stevens T; Livingston G; Ince P; McKeith IG; Katona CL
    J Neurol Neurosurg Psychiatry; 2002 Aug; 73(2):134-40. PubMed ID: 12122169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia.
    Spehl TS; Frings L; Hellwig S; Weiller C; Hüll M; Meyer PT; Amtage F
    Clin Nucl Med; 2015 Jan; 40(1):e27-33. PubMed ID: 25140560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
    Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.